A multi-center randomized, double-blind, placebo controlled, parallel-group study of CD 07743 for the improvement of Lateral Canthal Lines (crow’s feet)
- Conditions
- Moderate to severe Lateral Canthal LinesMedDRA version: 12.1Level: LLTClassification code 10052609Term: Glabellar frown lines
- Registration Number
- EUCTR2010-021936-33-DE
- Lead Sponsor
- Galderma R&D SNC
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 324
Inclusion Criteria
Male and female subjects, 18 to 65 years of age with moderate or severe (grade 2 or 3) Lateral Canthal Lines at maximum smile and with mild to severe (grade 1, 2, or 3) Lateral Canthal Lines at rest.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
Subjects who had any prior surgery affecting the orbicularis oculi muscle, prior blepharoplasty or brow lift, or any prior cosmetic procedures or scars that may interfere with the evaluation of the study results will not be included in this study
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method